My InsideMarket Private Fund does not own shares in Brainchip at the time of publishing this post, nor have we received any payment for this coverage. More on disclosure at end of post.
CEO's that excitedly tell you an entire sector like AI is their target, often miss hitting the board all together.
Simply put - there's no great upside in being a jack of all trades and master of none - especially if you are in the disruptive technology (DT) space.
So it is refreshing to hear the phrase "It's not what to do, but which to do" from a DT CEO.
Louis DiNardo, CEO of Brainchip, has identified the chip maker's real strength is at what is called the "The edge" of of AI.
• “AI at the Edge” is a high-volume, high-growth market.
• Intelligence is provided and analytics are performed at the point of acquiring data rather than data being transferred to a central processing core in a data centre or in the cloud for analysis and action.
"The edge" is where the Branchip's proprietary chip, AKIDA, says it will help make AI based analytic computing, faster, more accurate, and even have the ability to learn at the edge.
For example, in an autonomous vehicle, the AKIDA chip could do a reasonable amount of data processing, literally next to a camera embedded into the front bumper.
This would eliminate the time it takes for the data to be sent to the cloud, a data centre or a computer in the boot/trunk of the car.
Reducing the reaction time of an autonomous vehicle is vital to their success.
Of course this makes good sense, but to achieve this is not easy as it might seem. And that is where AKIDA comes in.
The Akida Neuromorphic System-on-Chip (NSoC) is the first in a new breed of neuromorphic computing.
Neuromorphic computing is a branch of artificial intelligence (AI) that simulates the functionality of neurons in the human brain.
Brainchip has been working away at getting some commercial deals locked in and it seems like it might be getting close, according to CEO Louis DiNardo.
Disruptive technology stocks should be considered very speculative, high-risk, and extremely volatile. There are significant risks inherent in developing new technologies that are not discussed here. You should always seek professional advice before considering any share purchase or sale. Please read our full disclaimer.